Thaks AB12 -- I got in HEB at 2.35 and GNVC at .64 (though more in HEB :[ ), so I am still in profit territory. I must admit though, with ASCO and supposed news from FDA, I've held several of these biotech/drug stocks longer than I normally do. I guess unfortunately most lessons come with a price.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.